Quality-by-Design drug formulation development; high protein concentration formulations; cytotoxic and ADC formulation development; virus and liposomal formulation development; lyophilization and bulk lyophilization process development; aseptic non-GMP pilot/preclinical batch manufacturing of liquid and lyophilized products; aseptic compounding with pre-sterilized components and final sterile filtration; permeable lyophilization bags; pre-filled syringescartridges and dual-chamber systems; downstream process development; analytical services and method development; technology transfer to fill & finish.